TRAIL Receptor Signaling Regulation of Chemosensitivity In Vivo but Not In Vitro

Abstract

BackgroundSignaling by Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) and Fas ligand (FasL) has been proposed to contribute to the chemosensitivity of tumor cells treated with various other anti-cancer agents. However, the importance of these effects and whether there are differences in vitro and in vivo is unclear.Methodology/Principal FindingsTo assess the relative contribution of death receptor pathways to this sensitivity and to determine whether these effects are intrinsic to the tumor cells, we compared the chemosensitivity of isogenic BJAB human lymphoma cells where Fas and TRAIL receptors or just TRAIL receptors were inhibited using mutants of the adaptor protein FADD or by altering the expression of the homeobox transcription factor Six1. Inhibition of TRAIL receptors did not affect in vitro tumor cell killing by various anti-cancer agents indicating that chemosensitivity is not significantly affected by the tumor cell-intrinsic activation of death receptor signaling. However, selective inhibition of TRAIL receptor signaling caused reduced tumor regression and clearance in vivo when tested in a NOD/SCID mouse model.ConclusionsThese data show that TRAIL receptor signaling in tumor cells can determine chemosensitivity in vivo but not in vitro and thus imply that TRAIL resistance makes tumors less susceptible to conventional cytotoxic anti-cancer drugs as well as drugs that directly target the TRAIL receptors.

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics

“…Indeed, in a recent study by Menke et al, selective inhibition of TRAIL receptors reduced chemosensitivity in vivo but not in vitro (109). In addition, because of the complexity and the redundancy of the apoptosis machinery, too focused an approach may be as ineffective as no approach.…”

PPAR-α activation reduced LPS-induced inflammation in alveolar epithelial cells

“…Our results implicate for the first time that PPAR-α activation in AEC by fibrates necessarily is dependent on the presence of a functional living organism. The principle phenomenon of in-vivo effects not being reproducible in an in-vitro setting is numerous times described until now [33,34] implicating the importance of interactions by different cell types (e.g., macrophages) or signaling cascades only present in-vivo.…”

Interaction of Calf Thymus DNA with the Ni(II) Complex of Sodium 1,4-Dihydroxy-9,10-Anthraquinone-2-Sulphonate: A Novel Method of Analysis Using Cyclic Voltammetry

“…In order to develop cheap but efficient substitutes of anthracycline drugs, different analogues are being tried clinically [2,[24][25][26][27][28], and efforts are on going to modify the quinone moiety. One route to such modification has been through complex formation using metal ions that 2 International Journal of Electrochemistry reduce formation of superoxide, generating less cardiotoxic yet active anthracyclines [29,30].…”